|Videos|December 15, 2015
- Breast Cancer (Issue 2)
- Volume 1
- Issue 2
Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast Cancer
Author(s)Matthew J. Ellis, MD, PhD
Matthew J. Ellis, MD, PhD, director, Sue Smith Breast Center at Baylor College of Medicine, discusses a recent study of palbociclib in primary breast cancer.
Matthew J. Ellis, MD, PhD, director, Sue Smith Breast Center at Baylor College of Medicine, discusses a recent study of palbociclib in primary breast cancer. Ellis says while all the data on palbociclib prior to this study was in metastatic disease, this study looked at the treatment in the neoadjuvant setting for patient with breast cancer.
Articles in this issue
almost 10 years ago
Dr. Carey Anders on Treating Brain Metastases in Breast Canceralmost 10 years ago
Avelumab Shows Efficacy in PD-L1-Positive Metastatic Breast Canceralmost 10 years ago
Study Links pCR Post-Neoadjuvant Therapy to Increased Survival Rates in TNBCRelated Content
Advertisement
